𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Class III β-tubulin in human development and cancer

✍ Scribed by Katsetos, Christos D. ;Herman, Mary M. ;Mörk, Sverre J.

Book ID
102100287
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
490 KB
Volume
55
Category
Article
ISSN
0886-1544

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Class III β-Tubulin isotype (β III) in t
Class III β-Tubulin isotype (β III) in the adrenal medulla: II. Localization in primary human pheochromocytomas
✍ Karkavelas, George ;Katsetos, Christos D. ;Geddes, Jennian F. ;Herman, Mary M. ; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

## Background: The class iii beta-tubulin isotype (beta iii) is expressed specifically in central and peripheral nervous system neurons at various stages of neuronal differentiation. we have shown previously that beta iii is expressed in a differentiation-dependent manner in human neuroblastomas ar

Class III β-tubulin and the cytoskeletal
Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer
✍ Marta De Donato; Marisa Mariani; Lella Petrella; Enrica Martinelli; Gian Franco 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract The Class III β‐tubulin isotype (βIII‐tubulin) is a predictive biomarker in ovarian cancer and other solid tumor malignancies. We discovered that βIII‐tubulin function is linked to two GTPases: guanylate‐binding protein 1 (GBP1), which activates its function, and GNAI1, which inhibits i

Mutational analysis of the class I β-tub
Mutational analysis of the class I β-tubulin gene in human breast cancer
✍ Seiichi Hasegawa; Yasuo Miyoshi; Chiyomi Egawa; Makoto Ishitobi; Yasuhiro Tamaki 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB

Non-small cell lung cancers have a high incidence of somatic mutations of the beta-tubulin (class I) gene, suggesting involvement in the acquisition of resistance to taxanes, which exert their effects through binding to beta-tubulin. Since taxanes are often used in the treatment of breast cancer, we